Eli Lilly&Co (NYSE:LLY). experienced a decrease in share value for the second consecutive day, with a 3.42% drop on Thursday, closing at $550.13. This downturn is part of a broader decline in the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average also witnessing declines of 1.64% and 1.08%, ending at 4,330.00 and 34,070.42 respectively.
The pharmaceutical giant's closing price was $51.71 below its 52-week high of $601.84, achieved on September 14, 2023. In comparison to other companies in the same sector on Thursday, Eli Lilly&Co.'s performance was less impressive. For instance, Johnson&Johnson (NYSE:JNJ) experienced a lesser decline of 0.77%, with its shares closing at $161.66.
In addition to the decline in share value, another significant aspect of Thursday's trading was the volume of shares traded for Eli Lilly&Co., which stood at 4 million, surpassing its 50-day average trading volume of 2.9 million.
The data for this report is derived from information provided by Dow Jones and FactSet, as part of an automated analysis by a technology provider specializing in market data automation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.